Non-small cell lung cancer late-course accelerated hyperfractionated analysis of the efficacy of concurrent chemotherapy and radiotherapy.doc
- 1、本文档共8页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Non-small cell lung cancer late-course accelerated hyperfractionated analysis of the efficacy of concurrent chemotherapy and radiotherapy
PAGE \* MERGEFORMAT 8
Non-small cell lung cancer late-course accelerated hyperfractionated analysis of the efficacy of concurrent chemotherapy and radiotherapy
Authors: ZHOU Su-zhu, HUANG Guo-fu, Zhang Mujuan, Liang Wenyong
Abstract [Objective] To observe locally advanced non-small cell lung cancer after conventional radiotherapy to the late-course accelerated hyperfractionated radiotherapy synchronization EP chemotherapy efficacy and adverse reactions. [Methods] (1) radiotherapy alone group of 80 cases of the first 2 / 3 courses of conventional radiotherapy 40Gy located around after 1 / 3 of course be changed after the shrinking wild-course accelerated hyperfractionation radiotherapy. (2) concurrent chemotherapy and radiotherapy group of 54 cases, while in the above was added 5-cycle EP regimen. [Results] concurrent chemotherapy and radiotherapy alone group and 1 year, 2 years, 3-year survival rates were 66.7% (36/54), 38.9% (21/54), 18.5% (10/54) and 41.3% (33 / 80), 16.2% (13/80), 7.5% (6 / 80), 2-year survival rate was significantly different (χ2 = 8.73, P lt;0.01), effective rates were 88.9% and 55.0% (χ2 = 16.849, P lt;0.01). [Conclusion] after conventional radiotherapy to the late-course accelerated hyperfractionated concurrent chemotherapy and radiotherapy can improve local control rate and survival rate.
Keywords: non-small cell lung cancer
1 Materials and methods
1.1 Case Selection
A total of 134 cases of two groups of non-small cell lung cancer patients were confirmed by pathology or cytology. According to international TNM staging criteria, stage of disease for stage Ⅲ ~ Ⅳ, of which 81 cases of stage Ⅲ, Ⅳ period of 53 cases; pathological types: squamous cell carcinoma 78 cases, 30 cases of adenocarcinoma, squamous carcinoma 26 cases; aged 19 years ~ 74. Male 85 cases, female 49 cases. Karnofsky score 50 to 90 minutes, with an average of 71.4 points; tumor location: central type in 97 cases, 37 cases of periphera
您可能关注的文档
- No strategic marketing management- mental to the physical degradation-.doc
- No pros and cons of channel model for the optimal.doc
- No stem hip arthroplasty Nursing.doc
- No winter thermal underwear first dive.doc
- No true enterprise democracy, there is no real corporate culture.doc
- No struggle not a man - Rimula struggle with economic application and writing the story of men.doc
- No way out short of the five off-season.doc
- No X-ray guidance to the lower cervical spine lateral mass screw Technology.doc
- No. 12 South China combat Marketing Forum.doc
- No walnut Tao Su.doc
- 2-红河州建筑施工安全生产标准化工地复核评分表(2022年修改版).docx
- 6.锡通项目2018年下半年工作会汇报材料(2018.7.9).docx
- 2018道路工程知识点汇总(新版).docx
- 附件3:月度生产例会安全汇报资料-站台门项目部.docx
- 附件2:广东建工集团2018年度科技成果汇总表.DOC
- 马武停车区、三汇停车区停车位管理系统,0#台账缺量.doc
- 攀成钢委办发〔2015〕19号(党风廉政建设责任考核与追究办法).doc
- 1-红河州建筑工程质量管理标准化复核评分表(2022年修改版).docx
- 中交第三公路工程局第四工程分公司项目经济合同结算管理办法(修订).doc
- 厂站安全操作规程汇编.doc
文档评论(0)